Cargando…

A procurement‐based classification of pharmaceutical supplies for diabetes disease management

BACKGROUND AND AIMS: Diabetes is among the most prevalent noncommunicable chronic diseases globally and carries a substantial expense in worldwide health care. Pharmaceutical supplies related to diabetes management account for 20%–40% of the disease's management cos, and this percentage continu...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulsalam, Yousef, Alibrahim, Abdullah, Alhuwail, Dari, Behbehani, Hashem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472233/
https://www.ncbi.nlm.nih.gov/pubmed/36177396
http://dx.doi.org/10.1002/hsr2.807
_version_ 1784789263415508992
author Abdulsalam, Yousef
Alibrahim, Abdullah
Alhuwail, Dari
Behbehani, Hashem
author_facet Abdulsalam, Yousef
Alibrahim, Abdullah
Alhuwail, Dari
Behbehani, Hashem
author_sort Abdulsalam, Yousef
collection PubMed
description BACKGROUND AND AIMS: Diabetes is among the most prevalent noncommunicable chronic diseases globally and carries a substantial expense in worldwide health care. Pharmaceutical supplies related to diabetes management account for 20%–40% of the disease's management cos, and this percentage continues to increase. This study examines the pharmaceutical expenses associated with one of the most common chronic diseases: diabetes. Specifically, we measure the extent to which patient health and demographic factors drive the annual cost of pharmaceutical supplies for diabetes management. Second, the study applied a procurement‐centric classification scheme to pharmaceutical items involved in diabetes treatment. METHODS: Data on 98,648 pharmaceutical‐dispensing transactions (related to 2828 patients) over 1 year were collected from a specialized diabetes health center. Pharmaceutical prices from the sample were compared internationally to ensure that the findings apply to other countries. The association between the item cost and the number of unique patients prescribed pharmaceutical products was estimated at the category and subcategory levels. RESULTS: Approximately 80% of total pharmaceutical expenditures were attributed to 20% of patients. Two of 20 pharmaceutical categories—anti‐diabetes drugs and insulin—accounted for 34% of products dispensed and 57% of total pharmaceutical expenditures. Age, body mass index, and diabetes type were essential factors in predicting supply cost per patient. CONCLUSION: Applying the portfolio purchasing model also suggested that some clinically similar items, like insulin types, are best procured through divergent procurement strategies or vendors for optimal cost efficiency. A better understanding of the diverse array of diabetes supplies can reveal opportunities for better strategic supply management. This supply classification approach can also be applied in other supply‐intensive specialties, such as orthopedics.
format Online
Article
Text
id pubmed-9472233
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-94722332022-09-28 A procurement‐based classification of pharmaceutical supplies for diabetes disease management Abdulsalam, Yousef Alibrahim, Abdullah Alhuwail, Dari Behbehani, Hashem Health Sci Rep Original Research BACKGROUND AND AIMS: Diabetes is among the most prevalent noncommunicable chronic diseases globally and carries a substantial expense in worldwide health care. Pharmaceutical supplies related to diabetes management account for 20%–40% of the disease's management cos, and this percentage continues to increase. This study examines the pharmaceutical expenses associated with one of the most common chronic diseases: diabetes. Specifically, we measure the extent to which patient health and demographic factors drive the annual cost of pharmaceutical supplies for diabetes management. Second, the study applied a procurement‐centric classification scheme to pharmaceutical items involved in diabetes treatment. METHODS: Data on 98,648 pharmaceutical‐dispensing transactions (related to 2828 patients) over 1 year were collected from a specialized diabetes health center. Pharmaceutical prices from the sample were compared internationally to ensure that the findings apply to other countries. The association between the item cost and the number of unique patients prescribed pharmaceutical products was estimated at the category and subcategory levels. RESULTS: Approximately 80% of total pharmaceutical expenditures were attributed to 20% of patients. Two of 20 pharmaceutical categories—anti‐diabetes drugs and insulin—accounted for 34% of products dispensed and 57% of total pharmaceutical expenditures. Age, body mass index, and diabetes type were essential factors in predicting supply cost per patient. CONCLUSION: Applying the portfolio purchasing model also suggested that some clinically similar items, like insulin types, are best procured through divergent procurement strategies or vendors for optimal cost efficiency. A better understanding of the diverse array of diabetes supplies can reveal opportunities for better strategic supply management. This supply classification approach can also be applied in other supply‐intensive specialties, such as orthopedics. John Wiley and Sons Inc. 2022-09-14 /pmc/articles/PMC9472233/ /pubmed/36177396 http://dx.doi.org/10.1002/hsr2.807 Text en © 2022 The Authors. Health Science Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Abdulsalam, Yousef
Alibrahim, Abdullah
Alhuwail, Dari
Behbehani, Hashem
A procurement‐based classification of pharmaceutical supplies for diabetes disease management
title A procurement‐based classification of pharmaceutical supplies for diabetes disease management
title_full A procurement‐based classification of pharmaceutical supplies for diabetes disease management
title_fullStr A procurement‐based classification of pharmaceutical supplies for diabetes disease management
title_full_unstemmed A procurement‐based classification of pharmaceutical supplies for diabetes disease management
title_short A procurement‐based classification of pharmaceutical supplies for diabetes disease management
title_sort procurement‐based classification of pharmaceutical supplies for diabetes disease management
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472233/
https://www.ncbi.nlm.nih.gov/pubmed/36177396
http://dx.doi.org/10.1002/hsr2.807
work_keys_str_mv AT abdulsalamyousef aprocurementbasedclassificationofpharmaceuticalsuppliesfordiabetesdiseasemanagement
AT alibrahimabdullah aprocurementbasedclassificationofpharmaceuticalsuppliesfordiabetesdiseasemanagement
AT alhuwaildari aprocurementbasedclassificationofpharmaceuticalsuppliesfordiabetesdiseasemanagement
AT behbehanihashem aprocurementbasedclassificationofpharmaceuticalsuppliesfordiabetesdiseasemanagement
AT abdulsalamyousef procurementbasedclassificationofpharmaceuticalsuppliesfordiabetesdiseasemanagement
AT alibrahimabdullah procurementbasedclassificationofpharmaceuticalsuppliesfordiabetesdiseasemanagement
AT alhuwaildari procurementbasedclassificationofpharmaceuticalsuppliesfordiabetesdiseasemanagement
AT behbehanihashem procurementbasedclassificationofpharmaceuticalsuppliesfordiabetesdiseasemanagement